Ondansetron reduces the craving of biologically predisposed alcoholics

Psychopharmacology

Volumn 160, Issue 4, 2002, Pages 408-413

  Johnson, Bankole A ^a   Roache, John D ^a   Ait Daoud, Nassima ^a   Zanca, Nursen A ^a   Velazquez, Madeline ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

5 HT3 antagonist; Alcoholism; Craving; Genotype; Human; Ondansetron; Serotonin (5 HT); Subtype; Treatment

Indexed keywords

ONDANSETRON; PLACEBO;

ABSTINENCE; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRINKING BEHAVIOR; DRUG EFFICACY; FACTORIAL ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROTONINERGIC SYSTEM; VISUAL ANALOG SCALE;

ADULT; ALCOHOLISM; ANALYSIS OF VARIANCE; BEHAVIOR, ADDICTIVE; CHI-SQUARE DISTRIBUTION; DOUBLE-BLIND METHOD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; ONDANSETRON; SEROTONIN ANTAGONISTS; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD;

EID: 0036201983     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1002-9     Document Type: Article

References (41)

1. Combining ondansetron and naltrexone reduces craving among biologically predisposed alcoholics: Corroboration of self-reported drinking by serum carbohydrate deficient transferrin, a biomarker
2. The obsessive compulsive drinking scale
3. A review of central 5-HT receptors and their function
4. 3 antagonists fail to affect ethanol self-administration of rats
5. 3 receptor in CNS disorders
6. 3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain
7. Drug abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats
8. Assessing craving for alcohol
9. 3 receptor antagonist, suppresses voluntary ethanol consumption in alcohol-preferring rats
10. 3 antagonist GR38032F (ondansetron) on benzodiazepine withdrawal in rats
11. Neurobiological basis of drug reinforcement
12. 3 antagonist ICS 205-930
13. Utility of biological markers during outpatient treatment of alcohol dependent patients: Carbohydrate deficient transferrin responds to moderate changes in alcohol consumption
14. Platelet serotonin uptake is higher in early-onset than in late-onset alcoholics
15. Serotonergic agents and alcoholism treatment: Rebirth of the subtype concept - An hypothesis
16. 3 receptor interactions in animals and humans
17. Cue reactivity in cocaine-dependent subjects: Effects of cue type and cue modality
18. Age of onset as a discriminator between alcoholic subtypes in a treatment-seeking outpatient population
19. 3 receptors
20. 3 binding
21. 4 receptors in terminal regions of the mesolimbic system
22. Neural mechanisms of drug reinforcement
23. Animal models of alcoholism: Neurobiology of high alcohol-drinking behavior in rodents
24. Effects of various serotonergic agents on alcohol intake and alcohol preference in Wistar rats selected at two different levels of alcohol preference
25. 3 receptors
26. Does urge to drink predict relapse after treatment
27. Timeline follow-back: A technique for assessing self-reported alcohol consumption
28. Carbohydrate-deficient transferrin in serum: A new marker of potentially harmful alcohol consumption reviewed
29. Ensuring balanced distribution of prognostic factors in treatment outcome research
30. Ondansetron alters human alcohol intoxication
31. Cognitive concepts of craving
32. 3 antagonist ondansetron on voluntary ethanol intake in rats and mice maintained on a limited access procedure
33. Constituents of craving in a clinical alcohol sample
34. A psychomotor stimulant theory of addiction